Skip to content
★ Sign in to follow
GM

Gina M. Wallar

Président, Services Pharmaceutiques
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 03 Mar 2022 for Neogenomics INC.

Insider track record

Disclosed buys
0
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Gina M. Wallar: trading record in brief

Gina M. Wallar is a declared insider of Neogenomics Inc (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 5 July 2021 to 1 March 2022, the count stands at 3 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 3 March 2022: a share grant, in Neogenomics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Gina M. Wallar

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total

3 of 3 declarations